Literature DB >> 8761177

Mouse and rat cystatin C: Escherichia coli production, characterization and tissue distribution.

K Håkansson1, C Huh, A Grubb, S Karlsson, M Abrahamson.   

Abstract

Recombinant mouse (Mus musculus) and rat (Rattus norvegicus) cystatin C were produced by expression in Escherichia coli, isolated and functionally characterized. The mouse and rat inhibitors were both fully active in titrations of papain. Determination of equilibrium constants for dissociation (Ki) for their complexes with the target proteinase, cathepsin B, produced values not largely different from that for human cystatin C (Ki 0.07-0.13 nM). Rabbit antisera against mouse and rat cystatin C were produced and used for improved affinity purification of the recombinant inhibitors. Affinity purified immunoglobulins isolated from the antiserum against mouse cystatin C were used for construction of a sensitive enzyme-linked immunosorbent assay. The assay was used to demonstrate a high degree of immunological cross-reactivity between mouse and rat cystatin C and could be used for cystatin C quantification in mouse and rat tissue homogenates. All tissues analyzed contained cystatin C, with a relative content very similar to that of human tissues. For all species, brain tissue contained the highest cystatin C amounts and liver the lowest, whereas kidney, spleen and muscle tissues were intermediate in content. In the mouse, a notable high cystatin C content in parotid gland tissue was observed. The high degree of similarity in distribution pattern and functional properties for mouse, rat and human cystatin C indicates that a murine model should be relevant for studies of the human disease, hereditary cystatin C amyloid angiopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761177     DOI: 10.1016/0305-0491(96)00025-9

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  16 in total

1.  Decreased metastatic spread in mice homozygous for a null allele of the cystatin C protease inhibitor gene.

Authors:  C G Huh; K Håkansson; C M Nathanson; U P Thorgeirsson; N Jonsson; A Grubb; M Abrahamson; S Karlsson
Journal:  Mol Pathol       Date:  1999-12

Review 2.  Cross-interactions between the Alzheimer Disease Amyloid-β Peptide and Other Amyloid Proteins: A Further Aspect of the Amyloid Cascade Hypothesis.

Authors:  Jinghui Luo; Sebastian K T S Wärmländer; Astrid Gräslund; Jan Pieter Abrahams
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

3.  Cystatin C Induces Insulin Resistance in Hippocampal Neurons and Promotes Cognitive Dysfunction in Rodents.

Authors:  Lan Luo; Jinyu Ma; Yue Li; Zongkang Hu; Chengfeng Jiang; Hao Cai; Cheng Sun
Journal:  Neurosci Bull       Date:  2018-04-17       Impact factor: 5.203

4.  Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with β-amyloid.

Authors:  Tyler J Perlenfein; Jacob D Mehlhoff; Regina M Murphy
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

5.  From Analysis of Ischemic Mouse Brain Proteome to Identification of Human Serum Clusterin as a Potential Biomarker for Severity of Acute Ischemic Stroke.

Authors:  Hailong Song; Hui Zhou; Zhe Qu; Jie Hou; Weilong Chen; Weiwu Cai; Qiong Cheng; Dennis Y Chuang; Shanyan Chen; Shuwei Li; Jilong Li; Jianlin Cheng; C Michael Greenlief; Yuan Lu; Agnes Simonyi; Grace Y Sun; Chenghan Wu; Jiankun Cui; Zezong Gu
Journal:  Transl Stroke Res       Date:  2018-11-21       Impact factor: 6.829

6.  Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells.

Authors:  M Bjarnadottir; B S Wulff; M Sameni; B F Sloane; D Keppler; A Grubb; M Abrahamson
Journal:  Mol Pathol       Date:  1998-12

7.  Cystatin C is an Independent Risk Factor and Therapeutic Target for Acute Ischemic Stroke.

Authors:  Bo Yang; Jiangtao Zhu; Zhigang Miao; Beiqun Zhou; Wei Ge; Heqing Zhao; Xingshun Xu
Journal:  Neurotox Res       Date:  2015-02-20       Impact factor: 3.911

8.  Up regulation of cathepsin K expression in articular chondrocytes in a transgenic mouse model for osteoarthritis.

Authors:  J P Morko; M Söderström; A-M K Säämänen; H J Salminen; E I Vuorio
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

Review 9.  Cystatin C in aging and in Alzheimer's disease.

Authors:  Paul M Mathews; Efrat Levy
Journal:  Ageing Res Rev       Date:  2016-06-19       Impact factor: 10.895

10.  Cystatin E/M suppresses legumain activity and invasion of human melanoma.

Authors:  Jon J Briggs; Mads H Haugen; Harald T Johansen; Adam I Riker; Magnus Abrahamson; Øystein Fodstad; Gunhild M Maelandsmo; Rigmor Solberg
Journal:  BMC Cancer       Date:  2010-01-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.